Abstract
The inability to produce a biological child can profoundly disturb mental and social wellbeing, although it does not in itself threaten physical health. Infertility is also a problem of global proportions, affecting about 4–14 % of couples worldwide (Nachtigall 2006), with estimates of couples experiencing involuntary childlessness for a least 1 year ranging from 10 to 30 %. After a long period of neglect, infertility is finally receiving increased public and research attention. Infertility treatments can assist those desperate to become parents, but they have also fallen under scrutiny for their potential adverse maternal and infant outcomes. In this chapter, we use a new data source and novel comparison group to consider the use of such services and their salient outcomes. Our application is to Texas, the second most populous and extensive state in the U.S., and which has some of its most glaring reproductive health disparities.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsNotes
- 1.
The U.S. standard certificate of live birth, first introduced in 1900, is the model for state birth certificates and provides reasonably accurate information for maternal demographic characteristics. It is revised every 10–15 years to improve data quality and the collection of comparable and relevant birth data (Kulczycki 2008).
- 2.
The U.S. Census Bureau collects and tabulates race and ethnicity data following the U.S. Office of Management and Budget’s (OMB) standards, the most recent issued in 1997. These identify five race groups: white, black or African-American, American Indian or Alaska Native, Asian, and Native Hawaiian or Other Pacific Islander. The Census Bureau also utilized a sixth category (‘some other race’). Hispanic-origin information is also collected to give data on ethnicity by two categories: “Hispanic or Latino” and “Not Hispanic or Latino.”
- 3.
U.S. teen pregnancy and birth rates declined by more than one-third over 1990–2008, but in 2008, their public costs (federal, state, and local) still amounted to $10.9 billion and in Texas, teen childbearing (with over 80 % of such births unintended) cost taxpayers at least $1,193 million, substantially more than for any other state (National Campaign to Prevent Teen and Unplanned Pregnancy 2011). Among other factors, the negative consequences for the children of teen mothers include increased costs for health care, child welfare and foster care, lost tax revenue due to decreased earnings and spending.
- 4.
Planned Parenthood uses private contributions and patient fees to provide abortions, but not federal or state funds as this is not permitted under U.S. law. The sharply curtailed funding has led to the closure of numerous clinics in the state.
- 5.
Medicaid is a joint federal-state program that finances health care for poor women. Under U.S. law, those who depend on Medicaid have to be able to access healthcare from clinics that accept Medicaid. The Medicaid-supported Women’s Health Program generates $9 in federal funding for every $1 dollar spent by Texas. This match makes it a very good investment for the state and provides a safety net that is often the only health care many low-income women receive. In 2011, a lower court overruled the measure to bar Planned Parenthood (the program’s largest provider, serving nearly half the women in the program with their primary health and family planning) and abortion affiliates from continuing as members of the Women’s Health Program. This move was then appealed by the powerful Republican governor, whose presidential candidacy and coveting of social conservatives led his party to push more firmly against spending money on contraception and further limit access to reproductive health services.
- 6.
Pre-eclampsia can be a dangerous pregnancy complication in which hypertension is diagnosed during the pregnancy along with significant amounts of protein in the urine (proteinuria). There is no known cure for this set of symptoms, whose most visible sign is elevated blood pressure (above normal for age, gender, and physiologic condition) but which may also involve more generalized damaged to the kidneys and liver. It is more common among women who are pregnant for the first time and in women with a multiple gestation (twins or multiple birth), and it may occur in the immediate post-partum period when it can be more dangerous. Some women develop pregnancy-induced hypertension (high blood pressure without proteinuria), which also requires careful monitoring of mother and fetus. Eclampsia can occur after the onset of pre-eclampsia and is an acute and life-threatening complication of pregnancy. This form of hypertension includes seizures or coma.
- 7.
In keeping with prior literature (Nuojoa-Huttunen et al. 1999), non-vertex presentation is considered here as a maternal outcome, although it can also be viewed as a predictor for other adverse infant outcomes. In this dataset, the most significant predictors of non-vertex presentation were twin and triplet or higher order births, type of infertility treatment, preterm birth, and low birthweight.
- 8.
The Apgar score, the very first test given to a newborn, is a systematic measure used for evaluating the physical condition of the infant at specific intervals following birth. Apgar scores range from 0 to 10, with scores 3 and below generally regarded as critically low and requiring immediate medical care (ACOG/AAP 2006). However, the Apgar score has its limitations and is neither a good indicator of long-term complications, nor of the etiology of a problem.
- 9.
The Special Supplemental Nutrition Program for Women, Infants and Children (abbreviated as WIC) is a Federal grant program whose target population are those at low-income and nutritionally at risk (for more information, see http://www.fns.usda.gov/wic/aboutwic/wicataglance.htm). To be eligible for WIC and for Medicaid during the time period evaluated, households had to have an income that was at or less than 185 % of the federal poverty level (i.e. an eligible family of four could earn up to $37,000 in 2006); and needed to have had a child younger than age 5 years, or a woman who was pregnant, breastfeeding, or up to 6 months postpartum (Texas Department of State Health Services 2012). Those with private health insurance can still apply for WIC and U.S. citizenship is not a requirement for eligibility.
- 10.
Results for plurality are calculated incidence rates, whereas other demographic characteristics and co-morbidities are prevalence rates because they were computed with cross-sectional data.
- 11.
This was evident when gestational age was studied as a continuous variable, although the preterm birth difference was not shown to be significantly different among the two infertility treatment groups when it was looked at as a categorical variable.
References
Abusief, M. E., Hornstein, M. D., & Jain, T. (2007). Assessment of United States fertility clinic websites according to the American Society for Reproductive Medicine (ASRM)/Society for Assisted Reproductive Technology (SART) guidelines. Fertility and Sterility, 87(1), 88–92.
ACOG/AAP [American College of Obstetricians and Gynecologists; American Academy of Pediatrics]. (2006). The Apgar score. ACOG Committee Opinion no. 333. Obstetrics and Gynecology, 107(5), 1209–1212.
Bridges, E. (2008). Texas’ youth: Focus on sexual and reproductive health. Washington, DC: Advocates for Youth. Available at: http://www.advocatesforyouth.org/publications/publications-a-z/641-texas-youth-focus-on-sexual-and-reproductive-health. Accessed 15 Apr 2012.
Bronson, R. (1997). How should the number of embryos transferred to the uterus following in-vitro fertilization be determined to avoid the risk of multiple gestation? Human Reproduction, 12(8), 1605–1618.
Carr, B. R., Blackwell, R. E., & Azziz, R. (2005). Essential reproductive medicine. New York: McGraw-Hill.
Centers for Disease Control and Prevention (CDC), American Society for Reproductive Medicine (ASRM), Society for Assisted Reproductive Technology (SART). (2011). 2009 assisted reproductive technology success rates: National summary and fertility clinic reports. Atlanta: U.S. Department of Health and Human Services (especially Section 5: ART Trends 2000–2009). Available at: http://www.cdc.gov/art/ART2009/section5.htm. Accessed 21 June 2012.
Chandra, A., & Stephen, E. H. (2010). Infertility service use among U.S. women: 1995 and 2002. Fertility and Sterility, 93(3), 725–736.
Chandra, A., Martinez, G. M., Mosher, W. D., Abma, J. C. & Jones, J. (2005). Fertility, family planning, and reproductive health of U.S. women: Data from the 2002 National Survey of Family Growth. Vital Health Statistics, 23(25), 1–160. Atlanta: National Center for Health Statistics. Available at: http://www.cdc.gov/nchs/data/series/sr_23/sr23_025.pdf. Accessed 21 June 2012.
Duwe, K. N., Reefhuis, J., Honein, M. A., Schieve, L. A., & Rasmussen, S. A. (2010). Epidemiology of fertility treatment use among U.S. women with liveborn infants, 1997–2004. Journal of Women’s Health, 19(3), 407–416.
Ferraretti, A. P., Goossens, V., de Mouzon, J., Bhattacharya, S., Castilla, J. A., Korsak, V., Kupka, M., Nygren, K. G., Nyboe Andersen, A., & The European IVF-monitoring (EIM) Consortium. (2012). Assisted reproductive technology in Europe, 2008: Results generated from European registers by ESHRE. Human Reproduction, 27(9), 2571–2584.
Fritz, M. A., & Speroff, L. (2011). Clinical gynecologic endocrinology and infertility (8th ed.). Philadelphia: Lippincott Williams & Wilkins.
Gleicher, N., Weghofer, A., & Barad, D. (2006). A formal comparison of the practice of assisted reproductive technologies between Europe and the USA. Human Reproduction, 21(8), 1945–1950.
Hansen, M., Bower, C., Milne, E., de Klerk, N., & Kurinczuk, J. J. (2005). Assisted reproductive technologies and the risk of birth defects – A systematic review. Human Reproduction, 20(2), 328–338.
Hollos, M., Larsen, U., Obono, O., & Whitehouse, B. (2009). The problem of infertility in high fertility populations: Meanings, consequences and coping mechanisms in two Nigerian communities. Social Science and Medicine, 68(11), 2061–2068.
Inhorn, M. C. (2003). Local babies, global science: Gender, religion, and in-vitro fertilization in Egypt. New York: Routledge.
Inhorn, M., & van Balen, F. (Eds.). (2002). Infertility around the globe: New thinking on childlessness, gender and reproductive technologies. Berkeley: University of California Press.
Inhorn, M. C., Ceballo, R., & Nachtigall, R. (2009). Marginalized, invisible, and unwanted: American minority struggles with infertility and assisted conception. In L. Culley, N. Hudson, & F. Van Rooij (Eds.), Marginalized reproduction: Ethnicity, infertility and reproductive technologies (pp. 181–197). London: Earthscan.
Jones, H. W., Cohen, J., Cooke, I., Kempers, R., Brinsden, P., & Saunders, D. (2011). International federation of fertility societies surveillance 2010. Fertility and Sterility, 95(2), 491.
Kulczycki, A. (2008). Birth certificates. In S. E. Boslaugh (Ed.), Encyclopedia of epidemiology (pp. 96–97). Thousand Oaks: Sage.
Kurinczuk, J. J., & Hockley, C. (2010). Fertility treatment in 2006 – A statistical analysis. London: Human Fertilisation and Embryology Authority, HFEA. Available at: http://www.hfea.gov.uk/docs/Fertility-treatments-2006.pdf. Accessed 20 July 2012.
Lu, E., Barfield, W. D., Wilber, N., Diop, H., Manning, S. E., & Fogerty, S. (2008). Surveillance of births conceived with various infertility therapies in Massachusetts, January–March 2005. Public Health Reports, 123(2), 173–177.
Macaluso, M., Wright-Schnapp, T. J., Chandra, A., Johnson, R., Satterwhite, C. L., Pulver, A., Berman, S. M., Wang, R. Y., Farr, S. L., & Pollack, L. A. (2010). A public health focus on infertility prevention, detection, and management. Fertility and Sterility, 93(1), 16.e1–10.
Marketdata Enterprises. (2009). U.S. Fertility clinics & infertility services: An industry analysis. Tampa: Marketdata Enterprises, Inc.
Martin, J. A., Hamilton, B. E., Ventura, S. J., Michelle, J. K., Osterman, M. J. K., Kirmeyer, S., Mathews, T. J., & Wilson, E. C. (2011). Births: Final data for 2009. National Vital Statistics Reports, 60(1), 1–102. Hyattsville: National Center for Health Statistics.
Myers, E. R., McCrory, D. C., Mills, A. A., Price, T. M., Swamy, G. K., Tantibhedhyangkul, J., Wu, J. M., & Matchar, D. B. (2008). Effectiveness of assisted reproductive technology (ART). Evidence Reports/Technology Assessments, 167, 1–195 (AHRQ Publication No. 08-E012). Rockville: Agency for Healthcare Research and Quality.
Nachtigall, R. (2006). International disparities in access to infertility services. Fertility and Sterility, 85(4), 871–875.
National Campaign to Prevent Teen and Unplanned Pregnancy. (2011). Counting it up: The public costs of teen childbearing. Washington, DC: National Campaign to Prevent Teen and Unplanned Pregnancy. Available at: http://www.thenationalcampaign.org/costs/. Accessed 15 Apr 2012.
NCHS [National Center for Health Statistics]. (2012). Key statistics from the National Survey of Family Growth. Special tabulations by NCHS. Available at: http://www.cdc.gov/nchs/nsfg/abc_list_i.htm#infertility. Accessed 9 July 2012.
Nuojua-Huttunen, S., Gissler, M., Martikainen, H., & Tuomivaara, L. (1999). Obstetric and perinatal outcome of pregnancies after intrauterine insemination. Human Reproduction, 14(8), 2110–2115.
Nyboe Andersen, A., Goosens, V., Bhattacharya, S., Ferraretti, A. P., Kupka, M. S., de Mouzon, J., Nygren, K. G., & The European IVF-monitoring (EIM) Consortium, for the European Society of Human Reproduction and Embryology (ESHRE). (2009). Assisted reproductive technology and intrauterine inseminations in Europe, 2005: Results generated from European registers by ESHRE. Human Reproduction, 24(6), 1267–1287.
Nygren, K. G., Nyboe Andersen, A., Felberbaum, R., Gianoroli, L., de Mouzon, J., & Members of ESHRE’s European IVF-monitoring (EIM). (2006). On the benefit of assisted reproduction techniques, a comparison of the USA and Europe. Human Reproduction, 21(8), 2194.
Osterman, M. J. K., Martin, J. A., Mathews, T. J., & Hamilton, B. E. (2011) Expanded data from the new birth certificate, 2008. National Vital Statistics Reports, 59(7), 1–28. Hyattsville: National Center for Health Statistics. Available at: http://www.cdc.gov/nchs/data/nvsr/nvsr59/nvsr59_07.pdf. Accessed 9 July 2012.
Pandian, Z., Bhattacharya, S., Ozturk, O., Serour, G., & Templeton, A. (2009). Number of embryos for transfer following in-vitro fertilization or intra-cytoplasmic sperm injection. Cochrane Database of Systematic Reviews, 2, CD003416.
Romundstad, L. B., Romundstad, P. R., Sunde, A., von During, V., Skjaerven, R., & Vatten, L. J. (2006). Increased risk of placenta previa in pregnancies following IVF/ICSI; A comparison of ART and non-ART pregnancies in the same mother. Human Reproduction, 21(9), 2353–2358.
Romundstad, L. B., Romundstad, P. R., Sunde, A., von During, V., Skjaerven, R., & Vatten, L. J. (2006). Increased risk of placenta previa in pregnancies following IVF/ICSI; A comparison of ART and non-ART pregnancies in the same mother. Human Reproduction, 21(9), 2353–2358.
Romundstad, L. B., Romundstad, P. R., Sunde, A., von During, V., Skjaerven, R., Gunnell, D., & Vatten, L. J. (2008). Effects of technology or maternal factors on perinatal outcome after assisted fertilization: A population-based cohort study. Lancet, 372(9640), 737–743.
Schieve, L. A., Rosenberg, D., Handler, A., Rankin, K., & Reynolds, M. A. (2006). Validity of self-reported use of assisted reproductive technology treatment among women participating in the pregnancy risk assessment monitoring system in five states, 2000. Maternal and Child Health Journal, 10(5), 427–431.
Schieve, L. A., Cohen, B., Nannini, A., et al. (2007). A population-based study of maternal and perinatal outcomes associated with assisted reproductive technology in Massachusetts. Maternal and Child Health Journal, 11(6), 517–525.
Schieve, L. A., Devine, O., Boyle, C. A., Petrini, J. R., & Warner, L. (2009). Estimation of the contribution of non-assisted reproductive technology ovulation stimulation fertility treatments to US singleton and multiple births. American Journal of Epidemiology, 170(11), 1396–1407.
Shanley, M. L., & Asch, A. (2009). Involuntary childlessness, reproductive technology, and social justice: The medical mask on social illness. Signs, 34(4), 851–874.
Sutcliffe, A. G., & Ludwig, M. (2007). Outcome of assisted reproduction. Lancet, 370(9584), 351–359.
Templeton, A., & Morris, J. K. (1998). Reducing the risk of multiple births by transfer of two embryos after in vitro fertilization. The New England Journal of Medicine, 339(9), 573–577.
Texas Department of State Health Services. (2012). Texas Department of State Health Services, Women, Infants and Children Program (WIC). Available at: http://www.dshs.state.tx.us/wichd/. Accessed 15 June 2012.
Wang, J. X., Norman, R. J., & Kristiansson, P. (2002). The effect of various infertility treatments on the risk of preterm birth. Human Reproduction, 17(4), 945–949.
Wellons, M. F., Lewis, C. E., Schwartz, S. M., Gunderson, E. P., Schreiner, P. J., Sternfeld, B., Richman, J., Sites, C. K., & Siscovik, D. S. (2008). Racial differences in self-reported infertility and risk factors for infertility in a cohort of black and white women-The CARDIA Women’s Study. Fertility and Sterility, 90(5), 1640–1648.
Wilcox, L. S., Kiely, J. L., Melvin, C. L., & Martin, M. C. (1996). Assisted reproductive technologies: estimates of their contribution to multiple births and newborn hospital days in the United States. Fertility and Sterility, 65(2), 361–366.
Acknowledgments
The authors would like to thank the Texas Department of State Health Services for granting access to data used in this study.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Dhall, S., Kulczycki, A. (2014). Using New Data and Improved Study Designs to Examine Infertility-Service Seeking and Adverse Maternal and Perinatal Outcomes in the South-Central United States. In: Kulczycki, A. (eds) Critical Issues in Reproductive Health. The Springer Series on Demographic Methods and Population Analysis, vol 33. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6722-5_6
Download citation
DOI: https://doi.org/10.1007/978-94-007-6722-5_6
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6721-8
Online ISBN: 978-94-007-6722-5
eBook Packages: MedicineMedicine (R0)